EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil

Tatiana Strava Corrêa, Paula Fontes Asprino, Eduarda Sabá Cordeiro de Oliveira, Ana Carolina Rathsam Leite, Luiza Weis iD, Maria Isabel Achatz, Claudiner Pereira de Oliveira, Renata Lazari Sandoval, Romualdo Barroso-Sousa

Genes · 16.07.2024 · 15 (7) · 928

DOI: 10.3390/genes15070928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 16.07.2024. Verfasst von Tatiana Strava Corrêa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Sírio-Libanês, Centro de Oncologia de Brasília, Brasília 71635-610, DF, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Germ-Line Mutation, Tumor Suppressor Protein p53, Genetic Predisposition to Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stand Up to Cancer (SU2C), The Instituto de Ensino e Pesquisa do Hospital Sirio-Libanes (IEP-HSL).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the high prevalence of TP53 pathogenic variants (PV) carriers in the South and Southeast regions of Brazil, germline genetic testing for hereditary breast cancer (HBC) is not available in the Brazilian public health system, and the prevalence of Li-Fraumeni syndrome (LFS) is not well established in other regions of Brazil. We assessed the occurrence of TP53 p.R337H carriers among women treated for breast cancer (BC) between January 2021 and January 2022 at public hospitals of Brasilia, DF, Brazil. A total of 180 patients who met at least one of the NCCN criteria for HBC underwent germline testing; 44.4% performed out-of-pocket germline multigene panel testing, and 55.6% were tested for the p.R337H variant by allelic discrimination PCR. The median age at BC diagnosis was 43.5 years, 93% had invasive ductal carcinoma, 50% had estrogen receptor-positive/HER2 negative tumors, and 41% and 11% were diagnosed respectively at stage III and IV. Two patients (1.11%) harbored the p.R337H variant, and cascade family testing identified 20 additional carriers. The TP53 p.R337H detection rate was lower than that reported in other studies from south/southeast Brazil. Nonetheless, identifying TP53 PV carriers through genetic testing in the Brazilian public health system could guide cancer treatment and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGerm-Line MutationTumor Suppressor Protein p53Genetic Predisposition to DiseaseHumansFemaleBrazilAdultMiddle AgedGenetic TestingPublic HealthLi-Fraumeni SyndromeAged

Stichwörter der Autor:innen

Li–Fraumeni syndromeTP53 p.R337Hbreast cancerhereditary cancer

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Hospital Sírio-Libanês, Centro de Oncologia de Brasília, Brasília 71635-610, DF, Brazil.
  • Instituto de Ensino e Pesquisa do Hospital Sírio Libanês, São Paulo 01308-060, SP, Brazil.
  • Faculdade de Medicina, Universidade de Brasilia (UNB), Brasília 70910-900, DF, Brazil.
  • Hospital Materno Infantil de Brasília (HMIB), Asa Sul 70203-900, DF, Brazil.
  • Instituto Hospital de Base do Distrito Federal (IHB-DF), Brasília 70330-150, DF, Brazil.
  • DASA Oncology, Hospital Brasília, Brasília 71681-603, DF, Brazil.

ORCID-Profile: Luiza Weis

Förderung

  • Stand Up to Cancer (SU2C)
  • The Instituto de Ensino e Pesquisa do Hospital Sirio-Libanes (IEP-HSL)

Zitieren

APA

Corrêa, T. S., Asprino, P. F., de Oliveira, E. S. C., Leite, A. C. R., Weis, L., Achatz, M. I., de Oliveira, C. P., Sandoval, R. L., & Barroso-Sousa, R. (2024). TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil. Genes, 15(7), 928. https://doi.org/10.3390/genes15070928

Vancouver

Corrêa TS, Asprino PF, de Oliveira ESC, Leite ACR, Weis L, Achatz MI, et al. TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil. Genes. 2024;15(7):928. doi:10.3390/genes15070928

BibTeX
@article{Corra2024,
  author = {Corrêa, Tatiana Strava and Asprino, Paula Fontes and de Oliveira, Eduarda Sabá Cordeiro and Leite, Ana Carolina Rathsam and Weis, Luiza and Achatz, Maria Isabel and de Oliveira, Claudiner Pereira and Sandoval, Renata Lazari and Barroso-Sousa, Romualdo},
  title = {TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {7},
  pages = {928},
  doi = {10.3390/genes15070928}
}
Kostenlos starten →